Kedalion Therapeutics is a clinical-stage, venture-funded ophthalmic drug company based in Menlo Park, CA. Kedalion's AcuStream technology delivers topical drugs to the eye in a precise and accurate manner that enables comparable efficacy with an 80% reduction in dose compared to standard drops, and a significantly improved side effect profile along with patient comfort and convenience following self-administration.
Location: United States, California, Menlo Park
Member count: 11-50
Total raised: $5M
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | Lagunita B... | lagunitabi... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 06.08.2018 | Series A | $5M | - | vcnewsdail... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 28.08.2020 | Podcast potpourri | Dr. Rahhal is quickly becoming a prolific podcaster. In this week's roundup Firas hosts three podcas... | exsightven... |
| 06.08.2018 | Kedalion Therapeutics Closes $5M Series A | MENLO PARK, CA, Clinical-stage company focused on the development and commercialization of topical... | vcnewsdail... |
| 06.08.2018 | Kedalion Therapeutics Closes $5 Million Series A Financing R... | MENLO PARK, Calif.–(BUSINESS WIRE)–August 6, 2018– Kedalion Therapeutics, Inc., a clinical-stage co... | venturebea... |
| 06.08.2018 | Kedalion raises $5M in Series A round for topical eye drug d... | According to medical research and media reports cited by the company, current methods for administer... | medcitynew... |
| - | Kedalion raises $5M in Series A round for topical eye drug d... | A company developing a system designed to reduce the amount of topical eye medication necessary to a... | medcitynew... |